Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LYMPHOCYTES for Myelodysplastic syndrome: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where LYMPHOCYTES was used for Myelodysplastic syndrome.

Most Reported Side Effects for LYMPHOCYTES

Side Effect Reports % Deaths Hosp.
Drug ineffective 12 24.5% 0 3
Disease progression 7 14.3% 1 2
Pneumonia 7 14.3% 3 1
Acute graft versus host disease 6 12.2% 0 0
Hypertension 6 12.2% 0 1
Sepsis 6 12.2% 1 1
Bacterial infection 5 10.2% 0 0
Chronic graft versus host disease 5 10.2% 0 0
Dry eye 5 10.2% 0 0
Dysphagia 5 10.2% 0 0
Extremity contracture 5 10.2% 0 0
Eye irritation 5 10.2% 0 0
Pain 5 10.2% 0 0
Quality of life decreased 5 10.2% 0 0

Other Indications for LYMPHOCYTES

Malignant melanoma (8) Acute myeloid leukaemia (7) Graft versus host disease (5)

Other Drugs Used for Myelodysplastic syndrome

LENALIDOMIDE (14,132) AZACITIDINE (5,741) VENETOCLAX (2,508) DEFERASIROX (1,445) DARBEPOETIN ALFA (1,164) RUXOLITINIB (886) REVLIMID (835) CEDAZURIDINE\DECITABINE (770) LUSPATERCEPT-AAMT (609) DECITABINE (429)

Related Pages

LYMPHOCYTES Full Profile All Myelodysplastic syndrome Drugs LYMPHOCYTES Demographics LYMPHOCYTES Timeline